Article

Patients Play an Important Role in Cancer Treatment

While it is the responsibility of the clinician to inform their patients of all options available, it is, in turn, vital for them to play a role in selecting the cancer treatment that’s right for them, according to Dr. Sara Hurvitz.

While it is the responsibility of the clinician to inform their patients of all options available, it is, in turn, vital for them to play a role in selecting the cancer treatment that’s right for them, according to Dr. Sara Hurvitz.

In an interview with CURE, Hurvitz, an associate professor of medicine at the University of California, Los Angeles, explained how doctors may educate and recommend various treatment options, but ultimately, patients are the ones who need to weigh their options and decide on the best course of therapy.

Transcript:

In my opinion, it’s imperative and ethical to have patients play a role in all of the treatment decisions. These are the people who are going to be assuming all of the toxicity and side effects — and the benefits, frankly – of a given therapy.

We as clinicians, it’s my opinion, that we need to educate our patients and empower them to help them make a decision. It’s certainly our responsibility as clinicians to make a recommendation for the treatment that has the best therapeutic index, meaning highest efficacy and lowest toxicity. But ultimately, the patient is the one that needs to buy in and decide which therapy they would like to proceed with.

Related Videos
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Bald Doctor.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Dr. Ritu Salani, the Director of Gynecologic Oncology at the University of California, Los Angeles (UCLA), UCLA Health, and a board-certified gynecologic oncologist.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Image of Dr. Braun.
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.